tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market
MLTX
MoonLake Immunotherapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

MoonLake Immunotherapeutics (MLTX) Stock News & Sentiment

Compare
325 Followers
MoonLake Immunotherapeutics Secures $500M Financing for Growth
Premium
Company Announcements
MoonLake Immunotherapeutics Secures $500M Financing for Growth
12d ago
8K
MLTX
MoonLake Immunotherapeutics’ Sonelokimab Positioned as Leading Treatment for Hidradenitis Suppurativa Amidst Weak JAK Inhibitor Competition
Premium
Ratings
MoonLake Immunotherapeutics’ Sonelokimab Positioned as Leading Treatment for Hidradenitis Suppurativa Amidst Weak JAK Inhibitor Competition
27d ago
MLTX
MoonLake Immunotherapeutics: Advancing Sonelokimab with Promising Phase III VELA Program and Favorable Market Positioning
Premium
Ratings
MoonLake Immunotherapeutics: Advancing Sonelokimab with Promising Phase III VELA Program and Favorable Market Positioning
29d ago
MLTX
MoonLake Immunotherapeutics Advances Clinical Trials in 2024
Premium
Company Announcements
MoonLake Immunotherapeutics Advances Clinical Trials in 2024
1M ago
MLTX
MoonLake Immunotherapeutics: Promising Prospects for Sonelokimab in Inflammatory Diseases
Premium
Ratings
MoonLake Immunotherapeutics: Promising Prospects for Sonelokimab in Inflammatory Diseases
1M ago
MLTX
Optimistic Outlook for MoonLake Immunotherapeutics: Promising Developments and Market Opportunities for Sonelokimab
Premium
Ratings
Optimistic Outlook for MoonLake Immunotherapeutics: Promising Developments and Market Opportunities for Sonelokimab
1M ago
MLTX
MoonLake Immunotherapeutics: Buy Rating Backed by Promising SLK Data and Strong Financial Position
Premium
Ratings
MoonLake Immunotherapeutics: Buy Rating Backed by Promising SLK Data and Strong Financial Position
2M ago
MLTX
More MLTX News >

MLTX News on the Web

MoonLake (MLTX) Secures $500M Non-Dilutive Financing to Advance Sonelokimab
GuruFocus News
Neutral
MoonLake Immunotherapeutics Secures $500 Million Non-Dilutive Financing from Hercules Capital
GuruFocus News
Bullish
MoonLake Immunotherapeutics Advances Clinical Trials in 2024
TipRanks News
Neutral
Is MoonLake Immunotherapeutics An Oversold Biotech Stock to Buy Now?
Yahoo Finance
Neutral
MoonLake Immunotherapeutics : the Most Oversold Pharma Stock to Buy According to Analysts
Yahoo Finance
Neutral
MoonLake Immunotherapeutics : Among the Most Oversold Healthcare Stocks to Buy Now
Yahoo Finance
Neutral
We're Hopeful That MoonLake Immunotherapeutics Will Use Its Cash Wisely
Yahoo Finance
Neutral
Stocks making the biggest moves midday: Novo Nordisk, J.B. Hunt, Qorvo and more
CNBC
Neutral

News Score - Last 7 Days

Neutral
MLTX
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week99%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MLTX’s Media Buzz Sentiment?
Currently, no data Available
What is MLTX’s weekly average amount of articles?
Currently, no data Available
What is MLTX’s News Sentiment?
99% of articles about MLTX were positive this week, compared to its sector average of 59%.
    Healthcare Stocks that are Trending in the News
    THTXTheratechnologies
    NKTRNektar Therapeutics
    SENSSenseonics Holdings
    MBOTMicrobot Medical
    ARGXArgenx Se
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing